| Tag | Content |
|---|
EnhancerAtlas ID | HS019-07109 |
Organism | Homo sapiens |
Tissue/cell | CD20+ |
Coordinate | chr17:44221070-44222820 |
SNPs | | Number: 1 | ID | Chromosome | Position | Genome Version |
|
TF binding sites/motifs | | TF | JASPAR ID | Coordinate | Motif Sequence | Strand | -Log10(p-value) |
| RORA(var.2) | MA0072.1 | chr17:44221474-44221488 | TATAATTAGGTCAA | + | 7.47 | | RUNX1 | MA0002.2 | chr17:44221773-44221784 | AAACCACAGAA | - | 6.32 |
|
| | Number of super-enhancer constituents: 4 | ID | Coordinate | Tissue/cell |
| SE_09447 | chr17:44220972-44224115 | CD14 | | SE_11745 | chr17:44220909-44226381 | CD20 | | SE_13432 | chr17:44221381-44222521 | CD34_Primary_RO01536 | | SE_18395 | chr17:44221223-44224075 | CD4p_CD25-_Il17-_PMAstim_Th |
|
| | Diseases: AD,Huntington,Obesity,Parkinson,Prostate cancer,Schizophrenia and Sleep disorder | | Number of disease enhancers: 5 | Chromosome | Start | End |
| chr17 | 44221199 | 44221535 | | chr17 | 44222069 | 44222124 | | chr17 | 44221587 | 44221653 | | chr17 | 44221663 | 44222002 | | chr17 | 44222148 | 44222736 |
|
| | Number: 1 | ID | Chromosome | Start | End |
| GH17I046145 | chr17 | 44222461 | 44223966 |
|
Enhancer Sequence | GAGGCAGGAG AATGGCGTGA ACCCAGGAGG CAGAGCTTGC AGTGAGCCGA GATCACGCCA 60
CTGCCCTCCA GCCTGGGCGA CAGAGCGAGA CTCCATCTCA AAAAAAAAAA AAAAAAAAAA 120
AAAAGAAGTT GTTATCTTCC CAGTAGAAGA GATGAGAAAA TTTGAGGTCC AGATTGGTTG 180
AGTGATATCC GAGGACCACA GAGCTAGTAA AATTATGGAG CTAGAACTTG AAGTCTGATT 240
CCAAATCACA TGTTTCCTAT GCTACCCCAA ACAAAGGGAG TATTTTCTAC AGTGGCATTA 300
CAACAGACCA AGTAACAGCA GAGGTAAAAC AAGTTTCACA TGTCTGTGGC TCTTTGTTTT 360
TTACAAGTTT TTATTACTTT GTCATGGGGG GGAAAACGAA AAATTATAAT TAGGTCAAGG 420
AAAGATATAA CTATACTACT ACTATCATTC TGAAGGAAGG GAAGGTATAC CTTCTAAGTC 480
CTGCATAGTT TAAAAATTCC CATTACTTGC GAGACCAGGT GAGACTGCAC AGTTCTAGAC 540
TTCCTATCGT GTGCCAAAAC TCTAGGGATA ATCAAAAAAT GTTTGTTGAA TGAACGCTAA 600
TTTAAAATAG AAAAAGAAAT TCCAGATTTC CTCCTCAGTA CAAGAGGCCT GCAACAACAA 660
ACTTCTGAAA TACCAGCAGT CTACTAATTG CATATTCAAA TTTAAACCAC AGAAAGTTGA 720
ATCAACTCTG CCAATTTCTG GGACTCTCTA AATGAACTCT TAATACAAAA ATACATACTC 780
AGGCTCAGCA TTTTTTCTAA TCATTTACAA AAGTAAAAGG ACGTCAGGAC AAGTTCTGGT 840
GAAATTTTAT AAACAGCCAT GAATTGCAGC TGTAGACTGC CAGATACATA ACCTGTATAT 900
GACAGGGGGT ACCACGTGGA AATTAGAGAC ATCCCCCTTC ACCAAAAAGA TTATATCCAG 960
GGGATACTAC ATAATAAAAA AAAAATCTGA AAAATGTAAT GGGATTAAGA TCCTTTAGAA 1020
TAGGCTAGTA GTGATGATTT TGCTTTTTCA GTCCCCTCCT CACAAACAAA TGATGATGAC 1080
ACTGCCCTTA GCTTTCTATG TGCAAAGACA GTATTAACCT TCCCAGGCCA AACTTACGAC 1140
TACACCTTTT CCACACGAAA TGCAAGGCAT TTCTAACTCC CCAGATTACC TCACATTCGT 1200
TGGATGCCAC ACAATAGATT ATAAAGTATC AAGATATATA TTAATTTTTA AAAGTTCACC 1260
AGGAGTTGGA TATTCTAAAC TGGGTTTCTG ATTCTTAACA GTGAGAATGA AGTCAAGCTC 1320
CTTATTTGGT GGTTAGAGGA GAGGATTTGG CCAGAAATAA TTCTTTTAGG ATTGACAGAC 1380
AAGTACTACT TAAGTTCTAT CATCTCATCC AAAAACTTGC TTCTTATATT CTGCTTTTAA 1440
CCCGATCTAC ACAATGAAAA GCCACGGAGA CTAGTTTTGC ATGAAAGCAA AGGACTTTTC 1500
TAATATGACT TCAGAGCATG CCATGCTTTA AAGTCCATGT TCAACCACTT ACTATCATTT 1560
TCCAACTCAC TCTCTATGGG CCCATCCCAT ATTTCAACTA CAGGTATACC TCCTGGCCCT 1620
TTCTATTTCA TAAGCTTCTT TGGAAGACAA ATCTACTGAT TTATGCAATA AACTTTCTAC 1680
CTCTACTTAA CCAATTTGAT AATTTAATAG CTGGAGATAA TTCTAAATTC CCCAAACCTT 1740
AATCAAGAAT 1750
|
